Ignite Creation Date:
2024-05-06 @ 7:10 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02489578
Status:
UNKNOWN
Last Update Posted:
2015-10-16
First Post:
2015-03-16
Brief Title:
A Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China CAP-China
Sponsor:
Capital Medical University
Organization:
Capital Medical University
Study Overview
Official Title:
Management in Real-life of Patients Hospitalized With Community-acquired Pneumonia in China
Status:
UNKNOWN
Status Verified Date:
2015-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RSCAP-China
Brief Summary:
The purpose of this study is to evaluate the disease burden of hospitalized patients with CAP and healthcare-associated pneumonia HCAP in real life of China
Detailed Description:
In China the data about current management of patients hospitalized with CAP in the real-life setting is not availabletype of pneumonia selection of initial antibiotic time to clinical stability antibiotic choice anf modificationclinical outcomes and costs remain unclear
In this study we will collect comprehensive information on CAP and HCAP management patterns to evaluate the disease burden of hospitalized patients with CAP and HCAP in real life of China to analyze microbiological characteristicsclinical manifestationsantibiotic regimens adherences to guidelines and effect on outcome in different groups of patients with CAP and 65 years different comorbidities risk factors to investigate microbiological characteristicsclinical manifestationsantibiotic regimens adherences to guidelines and effect on outcome in different groups of disease severity with CAP to provide the difference on microbiological characteristicsclinical manifestationsantibiotic regimens and outcome between patients with CAP and HCAP to understand the current situation of antibiotic regimen to evaluate influence of different antibiotic regimens on prognosis
In this study we will collect comprehensive information on CAP and HCAP management patterns to evaluate the disease burden of hospitalized patients with CAP and HCAP in real life of China to analyze microbiological characteristicsclinical manifestationsantibiotic regimens adherences to guidelines and effect on outcome in different groups of patients with CAP and 65 years different comorbidities risk factors to investigate microbiological characteristicsclinical manifestationsantibiotic regimens adherences to guidelines and effect on outcome in different groups of disease severity with CAP to provide the difference on microbiological characteristicsclinical manifestationsantibiotic regimens and outcome between patients with CAP and HCAP to understand the current situation of antibiotic regimen to evaluate influence of different antibiotic regimens on prognosis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None